Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Ruegg, M A

Class:IdPerson:2328180
_displayNameRuegg, M A
_timestamp2012-06-25 14:46:01
created[InstanceEdit:2328179] Jupe, S, 2012-06-25
firstnameM A
initialMA
surnameRuegg
(author)[LiteratureReference:2328155] Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor
[LiteratureReference:2396228] Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane
[LiteratureReference:2396443] Agrin binds to the nerve-muscle basal lamina via laminin
[LiteratureReference:2467085] Interaction of agrin with laminin requires a coiled-coil conformation of the agrin-binding site within the laminin gamma1 chain
[LiteratureReference:2467098] An alternative amino-terminus expressed in the central nervous system converts agrin to a type II transmembrane protein
[LiteratureReference:2467687] Acetylcholine receptor-aggregating activity of agrin isoforms and mapping of the active site
[Change default viewing format]
No pathways have been reviewed or authored by Ruegg, M A (2328180)